BRAINSWAY (BRSYF) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 21, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 6-K for Q2 FY2025, filed Sep 30, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BRSYF SEC filings page.
BRAINSWAY LTD (BRSYF) reported $41.0M in revenue for fiscal year 2024, up 29.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
BrainsWay reached operating profitability in FY2024 as revenue growth created operating leverage while gross margins stayed broadly stable.
Gross margin barely changed, moving from73.9% in FY2023 to74.6% in FY2024. Over the same period, operating margin moved from-15.6% to3.4% , pointing to fixed-cost absorption or operating-expense leverage rather than a major change in product economics.
FY2024 operating cash flow was
FY2024 assets and liabilities rose
Financial Health Signals
BRAINSWAY LTD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
BRAINSWAY LTD scores 8.14, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $442.8M against total liabilities of $32.0M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
BRAINSWAY LTD passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, BRAINSWAY LTD generates $3.53 in operating cash flow ($10.3M OCF vs $2.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
BRAINSWAY LTD earns $0.92 in operating income for every $1 of interest expense ($1.4M vs $1.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q2 2025.
Cash & Balance Sheet
BRAINSWAY LTD held $67.9M in cash as of Q2 2025; no long-term debt figure is on record for that period.
Not reported for Q2 2025.
Not reported for Q2 2025.
Margins & Returns
None of these metrics is reported for Q2 2025.
Capital Allocation
None of these metrics is reported for Q2 2025.
BRSYF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
BRSYF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'256-K | Q4'246-K | Q4'2320-F | Q4'2220-F | Q4'2120-F | Q4'2020-F | Q3'206-K | Q4'1920-F |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $111.6M | $94.3M+49.8% | $63.0M-2.3% | $64.5M-14.9% | $75.7M+122.7% | $34.0M-12.2% | $34.4M-11.2% | $38.7M+64.1% |
| Current Assets | $89.0M | $79.7M+43.6% | $55.5M-4.5% | $58.1M-11.2% | $65.4M+169.4% | $24.3M-15.7% | $24.1M-16.5% | $28.8M+113.9% |
| Cash & Equivalents | $67.9M | $69.3M+559.2% | $10.5M-77.9% | $47.6M+181.2% | $16.9M-0.2% | $17.0M-21.7% | $15.8M-27.1% | $21.7M+141.7% |
| Inventory | $4.2M | $4.4M+19.1% | $3.7M-3.1% | $3.8M | N/A | N/A | N/A | N/A |
| Total Liabilities | $43.4M | $32.0M+49.6% | $21.4M+12.1% | $19.1M+3.7% | $18.4M+28.0% | $14.4M-1.0% | $14.5M-0.3% | $14.5M-12.8% |
| Current Liabilities | $25.5M | $15.3M+57.2% | $9.8M+19.9% | $8.1M-10.2% | $9.1M+33.3% | $6.8M+1.2% | $7.0M+3.8% | $6.7M-19.4% |
| Non-Current Liabilities | $17.9M | $16.7M+43.2% | $11.6M+6.3% | $10.9M+17.1% | $9.3M+23.3% | $7.6M-2.8% | $7.5M-3.9% | $7.8M-6.2% |
| Total Equity | $68.1M | $62.3M+49.9% | $41.6M-8.4% | $45.4M-20.8% | $57.3M+192.0% | $19.6M-18.9% | $19.9M-17.8% | $24.2M+248.4% |
| Retained Earnings | -$95.2M | -$98.4Mn/m | -$101.3Mn/m | -$97.1Mn/m | -$83.8Mn/m | -$77.3Mn/m | -$76.9Mn/m | -$71.9Mn/m |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments, Goodwill, Long-Term Debt.
BRSYF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'256-K | Q4'246-K | Q4'2320-F | Q4'2220-F | Q4'2120-F | Q4'2020-F | Q3'206-K | Q4'1920-F |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | $1.6Mn/m | N/A | -$1.2M |
| Depreciation & Amortization | N/A | N/A | N/A | N/A | N/A | -$833Kn/m | N/A | -$851K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | -$85K-74.9% | N/A | $338K |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | $1.6Mn/m | N/A | -$1.6M |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | $85Kn/m | N/A | -$396K |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | -$750Kn/m | N/A | -$414K |
Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.
BRSYF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.
Where BRAINSWAY LTD Ranks
Frequently Asked Questions
What is BRAINSWAY LTD's annual revenue?
BRAINSWAY LTD (BRSYF) reported $41.0M in total revenue for fiscal year 2024. This represents a 29.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is BRAINSWAY LTD's revenue growing?
BRAINSWAY LTD (BRSYF) revenue grew by 29.0% year-over-year, from $31.8M to $41.0M in fiscal year 2024.
Is BRAINSWAY LTD profitable?
Yes, BRAINSWAY LTD (BRSYF) reported a net income of $2.9M in fiscal year 2024, with a net profit margin of 7.1%.
What is BRAINSWAY LTD's EBITDA?
BRAINSWAY LTD (BRSYF) had EBITDA of $2.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is BRAINSWAY LTD's gross margin?
BRAINSWAY LTD (BRSYF) had a gross margin of 74.6% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is BRAINSWAY LTD's operating margin?
BRAINSWAY LTD (BRSYF) had an operating margin of 3.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is BRAINSWAY LTD's net profit margin?
BRAINSWAY LTD (BRSYF) had a net profit margin of 7.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is BRAINSWAY LTD's return on equity (ROE)?
BRAINSWAY LTD (BRSYF) has a return on equity of 4.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is BRAINSWAY LTD's operating cash flow?
BRAINSWAY LTD (BRSYF) generated $10.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are BRAINSWAY LTD's total assets?
BRAINSWAY LTD (BRSYF) had $94.3M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does BRAINSWAY LTD spend on research and development?
BRAINSWAY LTD (BRSYF) invested $7.2M in research and development during fiscal year 2024.
What is BRAINSWAY LTD's current ratio?
BRAINSWAY LTD (BRSYF) had a current ratio of 5.19 as of fiscal year 2024, which is generally considered healthy.
What is BRAINSWAY LTD's liabilities-to-equity ratio?
BRAINSWAY LTD (BRSYF) had a liabilities-to-equity ratio of 0.51 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2024, because the filing data we hold for that year carries no long-term debt figure.
What is BRAINSWAY LTD's return on assets (ROA)?
BRAINSWAY LTD (BRSYF) had a return on assets of 3.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is BRAINSWAY LTD's P/E ratio?
BRAINSWAY LTD (BRSYF) trades at 152x earnings, its market capitalization divided by $2.9M net income, FY2024. The market capitalization is $442.8M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is BRAINSWAY LTD's price-to-sales ratio?
BRAINSWAY LTD (BRSYF) trades at 10.8x sales, its market capitalization divided by $41.0M revenue, FY2024. The market capitalization is $442.8M as of Oct 21, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is BRAINSWAY LTD's Altman Z-Score?
BRAINSWAY LTD (BRSYF) has an Altman Z-Score of 8.14, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is BRAINSWAY LTD's Piotroski F-Score?
BRAINSWAY LTD (BRSYF) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are BRAINSWAY LTD's earnings high quality?
BRAINSWAY LTD (BRSYF) has an earnings quality ratio of 3.53x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can BRAINSWAY LTD cover its interest payments?
BRAINSWAY LTD (BRSYF) has an interest coverage ratio of 0.92x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.